There's a new path for building biotech companies called decentralized science (DeSci). We realize many might not know what this path looks like, what it means or why it matters so @0xsmac and I @CompoundVC have put together a playbook giving scientists, operators, and builders a path for understanding why and how to build in DeSci. Some highlights: More funding > funding from $2.3 trillion market cap of bitcoin vs. $776 billion market cap of Eli Lilly Solve cold-start data collection problems > you can coordinate global teams through tokens Build in weird areas > you're not beholden to having to appease old guards of biotech. You can get your radical ideas funded and built in DeSci. There are tradeoffs here and we discuss them in depth in the piece below.